EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Non‐synonymous , synonymous, and non‐coding nucleotide variants contribute to recurrently altered biological processes during retinoblastoma progression

Kevin Stachelek iD, Narine Harutyunyan, Susan Lee, Assaf Beck, Jonathan Kim, Liya Xu, Jesse L Berry iD, Aaron Nagiel, C Patrick Reynolds, A Linn Murphree, Thomas C Lee, Jennifer G Aparicio und 1 weitere

Genes, Chromosomes and Cancer · 2023

DOI: 10.1002/gcc.23120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, Chromosomes and Cancer, 2023. Verfasst von Kevin Stachelek und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Vision Center and Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Retinoblastoma, Retinal Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NEI NIH HHS, ALSF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinoblastomas form in response to biallelic RB1 mutations or MYCN amplification and progress to more aggressive and therapy‐resistant phenotypes through accumulation of secondary genomic changes. Progression‐related changes include recurrent somatic copy number alterations and typically non‐recurrent nucleotide variants, including synonymous and non‐coding variants, whose significance has been unclear. To determine if nucleotide variants recurrently affect specific biological processes, we identified altered genes and over‐represented variant gene ontologies in 168 exome or whole‐genome‐sequenced retinoblastomas and 12 tumor‐matched cell lines. In addition to RB1 mutations, MYCN amplification, and established retinoblastoma somatic copy number alterations, the analyses revealed enrichment of variant genes related to diverse biological processes including histone monoubiquitination, mRNA processing (P) body assembly, and mitotic sister chromatid segregation and cytokinesis. Importantly, non‐coding and synonymous variants increased the enrichment significance of each over‐represented biological process term. To assess the effects of such mutations, we examined the consequences of a 3′ UTR variant of PCGF3 (a BCOR‐binding component of Polycomb repressive complex I), dual 3′ UTR variants of CDC14B (a regulator of sister chromatid segregation), and a synonymous variant of DYNC1H1 (a regulator of P‐body assembly). One PCGF3 and one of two CDC14B 3′ UTR variants impaired gene expression whereas a base‐edited DYNC1H1 synonymous variant altered protease sensitivity and stability. Retinoblastoma cell lines retained only ~50% of variants detected in tumors and enriched for new variants affecting p53 signaling. These findings reveal potentially important differences in retinoblastoma cell lines and tumors and implicate synonymous and non‐coding variants, along with non‐synonymous variants, in retinoblastoma oncogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RetinoblastomaRetinal NeoplasmsHumansNucleotidesN-Myc Proto-Oncogene Protein3' Untranslated RegionsMutationGenes, RetinoblastomaDual-Specificity Phosphatases

Stichwörter der Autor:innen

cancer progressionnon-coding mutationsretinoblastomasynonymous mutations

Substanzen

NucleotidesN-Myc Proto-Oncogene Protein3' Untranslated RegionsCDC14B protein, humanDual-Specificity Phosphatases

Autor:innen und Institutionen

  • The Vision Center and Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Cancer Biology and Genomics Program, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Department of Ophthalmology and Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Department of Pediatrics and Cancer Center, Texas Tech University Health Sciences Center, School of Medicine, Lubbock, Texas, USA.
  • Department of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

ORCID-Profile: Kevin Stachelek, Jesse L Berry, David Cobrinik

Förderung

  • NCI NIH HHS
  • NEI NIH HHS
  • ALSF
  • Knights Templar Eye Foundation
  • National Institutes of Health
  • Research to Prevent Blindness
  • SBF

Zitieren

APA

Stachelek, K., Harutyunyan, N., Lee, S., Beck, A., Kim, J., Xu, L., Berry, J. L., Nagiel, A., Reynolds, C. P., Murphree, A. L., Lee, T. C., Aparicio, J. G., & Cobrinik, D. (2023). Non‐synonymous , synonymous, and non‐coding nucleotide variants contribute to recurrently altered biological processes during retinoblastoma progression. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.23120

Vancouver

Stachelek K, Harutyunyan N, Lee S, Beck A, Kim J, Xu L, et al. Non‐synonymous , synonymous, and non‐coding nucleotide variants contribute to recurrently altered biological processes during retinoblastoma progression. Genes, Chromosomes and Cancer. 2023. doi:10.1002/gcc.23120

BibTeX
@article{Stachelek2023,
  author = {Stachelek, Kevin and Harutyunyan, Narine and Lee, Susan and Beck, Assaf and Kim, Jonathan and Xu, Liya and Berry, Jesse L and Nagiel, Aaron and Reynolds, C Patrick and Murphree, A Linn and Lee, Thomas C and Aparicio, Jennifer G and Cobrinik, David},
  title = {Non‐synonymous , synonymous, and non‐coding nucleotide variants contribute to recurrently altered biological processes during retinoblastoma progression},
  journal = {Genes, Chromosomes and Cancer},
  year = {2023},
  doi = {10.1002/gcc.23120}
}
Kostenlos starten →